;wherein R′ is selected from the group consisting of H, OH, CONH2, COCH3, R″ is selected from the group consisting of H, CH3, R′″ represents H or CH3, and X− is a pharmaceutically acceptable counterion."/>
公开/公告号US2009118340A1
专利类型
公开/公告日2009-05-07
原文格式PDF
申请/专利号US20080287671
申请日2008-10-09
分类号A61K31/4425;A61P35/04;
国家 US
入库时间 2022-08-21 19:32:24